Key facts
- JiMED’s last known valuation is $4.8M (Feb 2025).
- It has raised $6.6M; the latest was Later Stage VC ($2.3M) in Feb 2025.
- Notable investors include Keio Innovation Initiative, Kyoto University Innovation Capital, Osaka University Venture Capital, Green Core.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for JiMED
- ·The full record, as it builds
Funding rounds
No funding rounds for JiMED are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About JiMED
Developer of wireless embedded brain-computer interface system designed to read brainiac activity. The company offers a wireless implantable system to read brain activity using an implanted device and artificial intelligence, and it operates the device by thinking, enabling amyotrophic lateral sclerosis patients to improve communication.
- Sector
- Healthcare
- HQ
- Suita, Japan
- Founded
- 2020
- Website
- jimed.jp/
- Ownership
- Privately Held (backing)
JiMED doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in JiMED shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on JiMED in its N-PORT filings yet. We sweep new filings monthly.